billS1816•Event Tuesday, May 20, 2025Analyzed

Improving Seniors’ Timely Access to Care Act of 2025

Bullish

Impact5/10

Oracle ($ORCL)UnitedHealth Group ($UNH)Elevance Health ($ELV)Humana ($HUM)CVS Health ($CVS)Healthcare Technology

Summary

The 'Improving Seniors’ Timely Access to Care Act of 2025' (S.1816) mandates electronic prior authorization for Medicare Advantage plans by 2028, creating a new market for EHR and prior authorization technology. This bill, with 67 cosponsors and a companion bill (HR3514) in the House, is currently in the early stages of the legislative process, having been referred to the Senate Committee on Finance. The mandate will drive demand for technology solutions in the healthcare sector.

Key Takeaways

1.S.1816 mandates electronic prior authorization for Medicare Advantage plans by 2028.
2.The bill creates a new market for EHR and prior authorization technology, benefiting healthcare IT providers.
3.Medicare Advantage providers will incur costs for compliance but may see long-term operational efficiencies.
4.The bill has strong bipartisan support and a House companion, increasing its likelihood of passage.

Market Implications

The mandate for electronic prior authorization will drive demand for technology solutions from companies like Oracle Corporation ($ORCL), which offers healthcare IT services. While the bill does not provide direct funding, it creates a regulatory requirement that will necessitate investment from Medicare Advantage plans. UnitedHealth Group Incorporated ($UNH), Elevance Health, Inc. ($ELV), Humana Inc. ($HUM), and CVS Health Corporation ($CVS) will be required to adopt these new systems, potentially impacting their operational expenditures and capital allocation for technology upgrades. Recent market data shows mixed performance among these companies. For instance, $ORCL has seen a 7-day gain of +4.86% but a 30-day decline of -5.98%. Conversely, $ELV and $HUM have experienced positive 7-day and 30-day changes, at +6.26% and +5.63% for $ELV, and +10.03% and +1.05% for $HUM, respectively. These movements reflect broader market dynamics and company-specific news, with the long-term implications of S.1816 still developing as the bill progresses through Congress.

Full Analysis

The 'Improving Seniors’ Timely Access to Care Act of 2025' (S.1816) was introduced in the Senate on May 20, 2025, and subsequently referred to the Committee on Finance. This bill aims to amend the Social Security Act by establishing requirements for prior authorization under Medicare Advantage plans. Specifically, it mandates that Medicare Advantage plans implement an electronic prior authorization program by January 1, 2028, and meet transparency requirements by January 1, 2027. This legislation does not directly appropriate funds but creates a regulatory mandate that will necessitate spending by Medicare Advantage plans on technology solutions. The money trail will involve Medicare Advantage plans contracting with technology providers for electronic health records (EHR) and prior authorization systems. While there is no explicit funding amount in the bill, the mandate will generate a new market for these services, with costs borne by the Medicare Advantage plans. Structural winners include technology companies specializing in healthcare IT, particularly those with existing EHR systems or prior authorization platforms, such as Oracle Corporation ($ORCL). Medicare Advantage providers like UnitedHealth Group Incorporated ($UNH), Elevance Health, Inc. ($ELV), Humana Inc. ($HUM), and CVS Health Corporation ($CVS) will be required to comply with the new electronic prior authorization standards, potentially increasing their operational expenses in the short term but streamlining processes in the long term. These companies will be the primary purchasers of the mandated technology. Looking at recent market data, Oracle Corporation ($ORCL) is currently at $145.54, showing a 7-day change of +4.86% but a 30-day change of -5.98%. UnitedHealth Group Incorporated ($UNH) is at $281.36, with a 7-day change of +7.48% and a 30-day change of -2.57%. Elevance Health, Inc. ($ELV) is at $302.61, with a 7-day change of +6.26% and a 30-day change of +5.63%. Humana Inc. ($HUM) is at $182.65, with a 7-day change of +10.03% and a 30-day change of +1.05%. CVS Health Corporation ($CVS) is at $73.28, with a 7-day change of +4.48% and a 30-day change of -6.88%. The bill's early stage means its potential impact is not yet fully reflected in these current price movements, which show mixed performance across the involved companies. As of 2026-04-07, the bill is in the early stages of the legislative process, having been referred to the Senate Committee on Finance. A companion bill, HR3514, exists in the House, indicating broad support and increasing the probability of eventual passage. Key legislative steps remaining include committee hearings, potential markups, a vote in the Senate, and then consideration by the House.